Department Of Epidemiology 4

151. Medicine storage, wastage, and associated determinants among urban households: a systematic review and meta-analysis of household surveys
152. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
153. Past, current status, and future trends of the rural healthcare network in the Republic of Kazakhstan
154. The impact of incentive scheme on rural healthcare workforce availability: a case study of Kazakhstan
155. Dynamics of Indicators Characterizing the Health of Kazakhstani Youth
156. A second update on mapping the human genetic architecture of COVID-19
157. A second update on mapping the human genetic architecture of COVID-19
158. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
159. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
160. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
161. Indoor air quality in Kazakh households: Evaluating PM_2.5 levels generated by cooking activities
162. Interrupted time series analysis of the impact of the COVID-19 pandemic and compulsory social health insurance system on fertility rates: a study of live births in Kazakhstan, 2019–2023
163. Kazakh version of the beck depression inventory: Validation study in female cancer patients
164. Prevalence of Anxiety Symptoms in Women Newly Diagnosed with Breast Cancer in Kazakhstan and Its Associated Factors
165. Burden of major cancer types in Almaty, Kazakhstan
166. Developing HPV Vaccination Communication Strategies: Assessing Knowledge, Attitudes, and Barriers Among Healthcare Professionals in Kazakhstan
167. Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: A mixed-methods study protocol
168. The prevalence of diabetes mellitus in Kazakhstan: A systematic review and meta-analysis
169. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
170. Patterns of menstrual cycle, menstrual pain and medication usage in young women from high- and middle-income countries
171. The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/ Rifampicin-Resistant Tuberculosis Cohort
172. Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysis
173. Healthcare providers’ perspectives and role in improving patient engagement in hiv treatment and care in almaty, kazakhstan
174. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
175. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
176. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
177. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
178. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
179. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
180. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
181. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
182. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
183. Evaluation of National Immunization Technical Advisory Groups (NITAGs) of middle-income countries in the WHO European Region; a synopsis
184. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
185. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
186. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
187. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
188. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
189. Neuropsychological Assessment of Community-Dwelling Older Adults in Almaty, Kazakhstan
190. Neuropsychological Assessment of Community-Dwelling Older Adults in Almaty, Kazakhstan
191. A bibliometric analysis of the impact of COVID-19 vaccines on the immune system (2020-2024)
192. A comparison of Gam-COVID-Vac vaccination and non-vaccination on neurological symptoms and immune response in post-COVID-19 syndrome
193. The Role of Memory T-Cell Mediated Immunity in Long-term COVID-19: Effects of Vaccination Status
194. Associations between serum levels of brain-derived neurotrophic factor, corticotropin releasing hormone and mental distress in vitiligo patients
195. Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients
196. Socio-behavioral determinants of early vs. long-term HIV infection in Kazakhstan: roles of self-testing, alcohol, drug use and sexual networks
197. Socio-behavioral determinants of early vs. long-term HIV infection in Kazakhstan: roles of self-testing, alcohol, drug use and sexual networks
198. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
199. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
200. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
1 2 3 4 5 6 9